Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate

ClinicalTrials.gov ID: NCT00262600

Public ClinicalTrials.gov record NCT00262600. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) Comparing the Efficacy and Safety of Two Blinded Doses of Dabigatran Etexilate With Open Label Warfarin for the Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation: Prospective, Multi-centre, Parallel-group, Non-inferiority Trial (RE-LY Study)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this trial is to demonstrate the efficacy and safety of dabigatran etexilate in patients with non-valvular atrial fibrillation for the prevention of stroke and systemic embolism.

Study identification

NCT ID
NCT00262600
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
18,113 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2005 (Actual)
Primary completion
Apr 2009 (Actual)
Completion
Not listed
Last update posted
Apr 17, 2019

Started 2005

United States locations

U.S. sites
374
U.S. states
46
U.S. cities
289
Facility City State ZIP Site status
1160.26.0009 Boehringer Ingelheim Investigational Site Birmingham Alabama — —
1160.26.0046 Boehringer Ingelheim Investigational Site Birmingham Alabama — —
1160.26.0057 Boehringer Ingelheim Investigational Site Birmingham Alabama — —
1160.26.0211 Boehringer Ingelheim Investigational Site Birmingham Alabama — —
1160.26.0206 Boehringer Ingelheim Investigational Site Huntsville Alabama — —
1160.26.0115 Boehringer Ingelheim Investigational Site Mobile Alabama — —
1160.26.0104 Boehringer Ingelheim Investigational Site Lake Havasu City Arizona — —
1160.26.0304 Boehringer Ingelheim Investigational Site Peoria Arizona — —
1160.26.0185 Boehringer Ingelheim Investigational Site Tucson Arizona — —
1160.26.0305 Boehringer Ingelheim Investigational Site Tucson Arizona — —
1160.26.0038 Boehringer Ingelheim Investigational Site Hot Springs Arkansas — —
1160.26.0302 Boehringer Ingelheim Investigational Site Jonesboro Arkansas — —
1160.26.0121 Boehringer Ingelheim Investigational Site Little Rock Arkansas — —
1160.26.0191 Boehringer Ingelheim Investigational Site Little Rock Arkansas — —
1160.26.0204 Boehringer Ingelheim Investigational Site Little Rock Arkansas — —
1160.26.0213 Boehringer Ingelheim Investigational Site Little Rock Arkansas — —
1160.26.0455 Boehringer Ingelheim Investigational Site Little Rock Arkansas — —
1160.26.0388 Boehringer Ingelheim Investigational Site Anaheim California — —
1160.26.0441 Boehringer Ingelheim Investigational Site Carmichael California — —
1160.26.0145 Boehringer Ingelheim Investigational Site French Camp California — —
1160.26.0333 Boehringer Ingelheim Investigational Site Fullerton California — —
1160.26.0384 Boehringer Ingelheim Investigational Site La Jolla California — —
1160.26.0091 Boehringer Ingelheim Investigational Site La Mesa California — —
1160.26.0246 Boehringer Ingelheim Investigational Site Lancaster California — —
1160.26.0345 Boehringer Ingelheim Investigational Site Larkspur California — —
1160.26.0217 Boehringer Ingelheim Investigational Site Loma Linda California — —
1160.26.0059 Boehringer Ingelheim Investigational Site Los Angeles California — —
1160.26.0088 Boehringer Ingelheim Investigational Site Los Angeles California — —
1160.26.0337 Boehringer Ingelheim Investigational Site Los Angeles California — —
1160.26.0326 Boehringer Ingelheim Investigational Site Mather California — —
1160.26.0070 Boehringer Ingelheim Investigational Site Merced California — —
1160.26.0349 Boehringer Ingelheim Investigational Site Oakland California — —
1160.26.0016 Boehringer Ingelheim Investigational Site Oceanside California — —
1160.26.0087 Boehringer Ingelheim Investigational Site Palm Springs California — —
1160.26.0459 Boehringer Ingelheim Investigational Site Pasadena California — —
1160.26.0216 Boehringer Ingelheim Investigational Site Redondo Beach California — —
1160.26.0135 Boehringer Ingelheim Investigational Site Riverside California — —
1160.26.0162 Boehringer Ingelheim Investigational Site Sacramento California — —
1160.26.0300 Boehringer Ingelheim Investigational Site Sacramento California — —
1160.26.0371 Boehringer Ingelheim Investigational Site Sacramento California — —
1160.26.0116 Boehringer Ingelheim Investigational Site San Diego California — —
1160.26.0148 Boehringer Ingelheim Investigational Site San Diego California — —
1160.26.0270 Boehringer Ingelheim Investigational Site San Diego California — —
1160.26.0284 Boehringer Ingelheim Investigational Site San Diego California — —
1160.26.0351 Boehringer Ingelheim Investigational Site Santa Ana California — —
1160.26.0043 Boehringer Ingelheim Investigational Site Santa Rosa California — —
1160.26.0462 Boehringer Ingelheim Investigational Site Sylmar California — —
1160.26.0276 Boehringer Ingelheim Investigational Site Torrance California — —
1160.26.0379 Boehringer Ingelheim Investigational Site Walnut Creek California — —
1160.26.0419 Boehringer Ingelheim Investigational Site Aurora Colorado — —
1160.26.0321 Boehringer Ingelheim Investigational Site Colorado Springs Colorado — —
1160.26.0449 Boehringer Ingelheim Investigational Site Colorado Springs Colorado — —
1160.26.0360 Boehringer Ingelheim Investigational Site Denver Colorado — —
1160.26.0413 Boehringer Ingelheim Investigational Site Denver Colorado — —
1160.26.0362 Boehringer Ingelheim Investigational Site Fort Collins Colorado — —
1160.26.0399 Boehringer Ingelheim Investigational Site Greeley Colorado — —
1160.26.0058 Boehringer Ingelheim Investigational Site Bridgeport Connecticut — —
1160.26.0241 Boehringer Ingelheim Investigational Site Bridgeport Connecticut — —
1160.26.0278 Boehringer Ingelheim Investigational Site Bridgeport Connecticut — —
1160.26.0085 Boehringer Ingelheim Investigational Site Fairfield Connecticut — —
1160.26.0482 Boehringer Ingelheim Investigational Site Guilford Connecticut — —
1160.26.0366 Boehringer Ingelheim Investigational Site Newark Delaware — —
1160.26.0343 Boehringer Ingelheim Investigational Site Washington D.C. District of Columbia — —
1160.26.0022 Boehringer Ingelheim Investigational Site Atlantis Florida — —
1160.26.0382 Boehringer Ingelheim Investigational Site Boynton Beach Florida — —
1160.26.0056 Boehringer Ingelheim Investigational Site Brandon Florida — —
1160.26.0105 Boehringer Ingelheim Investigational Site Clearwater Florida — —
1160.26.0296 Boehringer Ingelheim Investigational Site Clearwater Florida — —
1160.26.0429 Boehringer Ingelheim Investigational Site Clearwater Florida — —
1160.26.0376 Boehringer Ingelheim Investigational Site Daytona Beach Florida — —
1160.26.0411 Boehringer Ingelheim Investigational Site Deerfield Beach Florida — —
1160.26.0074 Boehringer Ingelheim Investigational Site Fort Myers Florida — —
1160.26.0239 Boehringer Ingelheim Investigational Site Gainesville Florida — —
1160.26.0260 Boehringer Ingelheim Investigational Site Hollywood Florida — —
1160.26.0265 Boehringer Ingelheim Investigational Site Hollywood Florida — —
1160.26.0100 Boehringer Ingelheim Investigational Site Inverness Florida — —
1160.26.0033 Boehringer Ingelheim Investigational Site Jacksonville Florida — —
1160.26.0089 Boehringer Ingelheim Investigational Site Jacksonville Florida — —
1160.26.0232 Boehringer Ingelheim Investigational Site Jacksonville Florida — —
1160.26.0240 Boehringer Ingelheim Investigational Site Jacksonville Florida — —
1160.26.0427 Boehringer Ingelheim Investigational Site Jacksonville Florida — —
1160.26.0464 Boehringer Ingelheim Investigational Site Jacksonville Florida — —
1160.26.0209 Boehringer Ingelheim Investigational Site Jacksonville Beach Florida — —
1160.26.0012 Boehringer Ingelheim Investigational Site Lakeland Florida — —
1160.26.0259 Boehringer Ingelheim Investigational Site Melbourne Florida — —
1160.26.0358 Boehringer Ingelheim Investigational Site Melbourne Florida — —
1160.26.0034 Boehringer Ingelheim Investigational Site Miami Florida — —
1160.26.0199 Boehringer Ingelheim Investigational Site Miami Florida — —
1160.26.0227 Boehringer Ingelheim Investigational Site Orlando Florida — —
1160.26.0095 Boehringer Ingelheim Investigational Site Ormond Beach Florida — —
1160.26.0037 Boehringer Ingelheim Investigational Site Pensacola Florida — —
1160.26.0076 Boehringer Ingelheim Investigational Site Pensacola Florida — —
1160.26.0081 Boehringer Ingelheim Investigational Site Pensacola Florida — —
1160.26.0111 Boehringer Ingelheim Investigational Site Pensacola Florida — —
1160.26.0137 Boehringer Ingelheim Investigational Site Port Charlotte Florida — —
1160.26.0389 Boehringer Ingelheim Investigational Site Port Charlotte Florida — —
1160.26.0417 Boehringer Ingelheim Investigational Site Port Charlotte Florida — —
1160.26.0332 Boehringer Ingelheim Investigational Site Rockledge Florida — —
1160.26.0226 Boehringer Ingelheim Investigational Site Safety Harbor Florida — —
1160.26.0031 Boehringer Ingelheim Investigational Site Sarasota Florida — —
1160.26.0385 Boehringer Ingelheim Investigational Site Sarasota Florida — —
1160.26.0015 Boehringer Ingelheim Investigational Site St. Petersburg Florida — —
1160.26.0339 Boehringer Ingelheim Investigational Site St. Petersburg Florida — —
1160.26.0010 Boehringer Ingelheim Investigational Site Stuart Florida — —
1160.26.0327 Boehringer Ingelheim Investigational Site Tamarac Florida — —
1160.26.0271 Boehringer Ingelheim Investigational Site Tampa Florida — —
1160.26.0328 Boehringer Ingelheim Investigational Site Tampa Florida — —
1160.26.0381 Boehringer Ingelheim Investigational Site Tampa Florida — —
1160.26.0019 Boehringer Ingelheim Investigational Site Vero Beach Florida — —
1160.26.0159 Boehringer Ingelheim Investigational Site Atlanta Georgia — —
1160.26.0283 Boehringer Ingelheim Investigational Site Atlanta Georgia — —
1160.26.0338 Boehringer Ingelheim Investigational Site Atlanta Georgia — —
1160.26.0021 Boehringer Ingelheim Investigational Site Augusta Georgia — —
1160.26.0319 Boehringer Ingelheim Investigational Site Augusta Georgia — —
1160.26.0092 Boehringer Ingelheim Investigational Site Blue Ridge Georgia — —
1160.26.0161 Boehringer Ingelheim Investigational Site Conyers Georgia — —
1160.26.0026 Boehringer Ingelheim Investigational Site Coeur d'Alene Idaho — —
1160.26.0218 Boehringer Ingelheim Investigational Site Berwyn Illinois — —
1160.26.0184 Boehringer Ingelheim Investigational Site Chicago Illinois — —
1160.26.0233 Boehringer Ingelheim Investigational Site Chicago Illinois — —
1160.26.0324 Boehringer Ingelheim Investigational Site Chicago Illinois — —
1160.26.0457 Boehringer Ingelheim Investigational Site Chicago Illinois — —
1160.26.0237 Boehringer Ingelheim Investigational Site Evanston Illinois — —
1160.26.0236 Boehringer Ingelheim Investigational Site Glenview Illinois — —
1160.26.0396 Boehringer Ingelheim Investigational Site Hines Illinois — —
1160.26.0438 Boehringer Ingelheim Investigational Site Maywood Illinois — —
1160.26.0331 Boehringer Ingelheim Investigational Site Melrose Park Illinois — —
1160.26.0364 Boehringer Ingelheim Investigational Site Normal Illinois — —
1160.26.0109 Boehringer Ingelheim Investigational Site North Chicago Illinois — —
1160.26.0152 Boehringer Ingelheim Investigational Site Oak Lawn Illinois — —
1160.26.0198 Boehringer Ingelheim Investigational Site Rockford Illinois — —
1160.26.0433 Boehringer Ingelheim Investigational Site Winfield Illinois — —
1160.26.0041 Boehringer Ingelheim Investigational Site Evansville Indiana — —
1160.26.0377 Boehringer Ingelheim Investigational Site Fort Wayne Indiana — —
1160.26.0288 Boehringer Ingelheim Investigational Site Indianapolis Indiana — —
1160.26.0352 Boehringer Ingelheim Investigational Site Indianapolis Indiana — —
1160.26.0436 Boehringer Ingelheim Investigational Site Indianapolis Indiana — —
1160.26.0028 Boehringer Ingelheim Investigational Site Jeffersonville Indiana — —
1160.26.0235 Boehringer Ingelheim Investigational Site South Bend Indiana — —
1160.26.0268 Boehringer Ingelheim Investigational Site Dubuque Iowa — —
1160.26.0001 Boehringer Ingelheim Investigational Site West Des Moines Iowa — —
1160.26.0189 Boehringer Ingelheim Investigational Site West Des Moines Iowa — —
1160.26.0357 Boehringer Ingelheim Investigational Site West Des Moines Iowa — —
1160.26.0354 Boehringer Ingelheim Investigational Site Wichita Kansas — —
1160.26.0077 Boehringer Ingelheim Investigational Site Bowling Green Kentucky — —
1160.26.0138 Boehringer Ingelheim Investigational Site Crestview Hills Kentucky — —
1160.26.0422 Boehringer Ingelheim Investigational Site Lexington Kentucky — —
1160.26.0178 Boehringer Ingelheim Investigational Site Louisville Kentucky — —
1160.26.0397 Boehringer Ingelheim Investigational Site Louisville Kentucky — —
1160.26.0310 Boehringer Ingelheim Investigational Site Owensboro Kentucky — —
1160.26.0011 Boehringer Ingelheim Investigational Site Baton Rouge Louisiana — —
1160.26.0144 Boehringer Ingelheim Investigational Site Baton Rouge Louisiana — —
1160.26.0404 Boehringer Ingelheim Investigational Site Baton Rouge Louisiana — —
1160.26.0093 Boehringer Ingelheim Investigational Site Covington Louisiana — —
1160.26.0340 Boehringer Ingelheim Investigational Site Lacombe Louisiana — —
1160.26.0018 Boehringer Ingelheim Investigational Site Lafayette Louisiana — —
1160.26.0391 Boehringer Ingelheim Investigational Site Lafayette Louisiana — —
1160.26.0252 Boehringer Ingelheim Investigational Site Morgan City Louisiana — —
1160.26.0132 Boehringer Ingelheim Investigational Site New Iberia Louisiana — —
1160.26.0299 Tulane University School Of Medicine New Orleans Louisiana — —
1160.26.0048 Boehringer Ingelheim Investigational Site Shreveport Louisiana — —
1160.26.0096 Boehringer Ingelheim Investigational Site Auburn Maine — —
1160.26.0068 Boehringer Ingelheim Investigational Site Scarborough Maine — —
1160.26.0114 Boehringer Ingelheim Investigational Site Annapolis Maryland — —
1160.26.0164 Boehringer Ingelheim Investigational Site Annapolis Maryland — —
1160.26.0023 Boehringer Ingelheim Investigational Site Baltimore Maryland — —
1160.26.0047 Boehringer Ingelheim Investigational Site Baltimore Maryland — —
1160.26.0079 Boehringer Ingelheim Investigational Site Baltimore Maryland — —
1160.26.0186 Boehringer Ingelheim Investigational Site Baltimore Maryland — —
1160.26.0194 Boehringer Ingelheim Investigational Site Baltimore Maryland — —
1160.26.0255 Boehringer Ingelheim Investigational Site Bel Air Maryland — —
1160.26.0398 Boehringer Ingelheim Investigational Site Columbia Maryland — —
1160.26.0177 Boehringer Ingelheim Investigational Site Rockville Maryland — —
1160.26.0073 Boehringer Ingelheim Investigational Site Salisbury Maryland — —
1160.26.0207 Boehringer Ingelheim Investigational Site Salisbury Maryland — —
1160.26.0196 Boehringer Ingelheim Investigational Site Takoma Park Maryland — —
1160.26.0187 Boehringer Ingelheim Investigational Site Towson Maryland — —
1160.26.0052 Boehringer Ingelheim Investigational Site Westminster Maryland — —
1160.26.0042 Boehringer Ingelheim Investigational Site Ayer Massachusetts — —
1160.26.0401 Boehringer Ingelheim Investigational Site Boston Massachusetts — —
1160.26.0160 Boehringer Ingelheim Investigational Site East Bridgewater Massachusetts — —
1160.26.0443 Boehringer Ingelheim Investigational Site Haverhill Massachusetts — —
1160.26.0452 Boehringer Ingelheim Investigational Site Haverhill Massachusetts — —
1160.26.0029 Boehringer Ingelheim Investigational Site Natick Massachusetts — —
1160.26.0446 Boehringer Ingelheim Investigational Site Newtown Massachusetts — —
1160.26.0003 Boehringer Ingelheim Investigational Site North Dartmouth Massachusetts — —
1160.26.0470 Boehringer Ingelheim Investigational Site Northborough Massachusetts — —
1160.26.0308 Boehringer Ingelheim Investigational Site Worcester Massachusetts — —
1160.26.0141 Boehringer Ingelheim Investigational Site Bloomfield Hills Michigan — —
1160.26.0225 Boehringer Ingelheim Investigational Site Detroit Michigan — —
1160.26.0154 Boehringer Ingelheim Investigational Site Grand Blanc Michigan — —
1160.26.0030 Boehringer Ingelheim Investigational Site Grand Rapids Michigan — —
1160.26.0171 Boehringer Ingelheim Investigational Site Kalamazoo Michigan — —
1160.26.0205 Boehringer Ingelheim Investigational Site Lapeer Michigan — —
1160.26.0279 Boehringer Ingelheim Investigational Site Muskegon Michigan — —
1160.26.0445 Boehringer Ingelheim Investigational Site Petoskey Michigan — —
1160.26.0274 Boehringer Ingelheim Investigational Site Rochester Hills Michigan — —
1160.26.0165 Boehringer Ingelheim Investigational Site Saginaw Michigan — —
1160.26.0020 Boehringer Ingelheim Investigational Site Troy Michigan — —
1160.26.0188 Boehringer Ingelheim Investigational Site Ypsilanti Michigan — —
1160.26.0131 Boehringer Ingelheim Investigational Site Minneapolis Minnesota — —
1160.26.0421 Boehringer Ingelheim Investigational Site Minneapolis Minnesota — —
1160.26.0202 Boehringer Ingelheim Investigational Site Robbinsdale Minnesota — —
1160.26.0101 Boehringer Ingelheim Investigational Site Saint Paul Minnesota — —
1160.26.0086 Boehringer Ingelheim Investigational Site Gulfport Mississippi — —
1160.26.0119 Boehringer Ingelheim Investigational Site Tupelo Mississippi — —
1160.26.0055 Boehringer Ingelheim Investigational Site Columbia Missouri — —
1160.26.0172 Boehringer Ingelheim Investigational Site Columbia Missouri — —
1160.26.0257 Boehringer Ingelheim Investigational Site Kansas City Missouri — —
1160.26.0266 Boehringer Ingelheim Investigational Site Kansas City Missouri — —
1160.26.0336 Boehringer Ingelheim Investigational Site Saint Charles Missouri — —
1160.26.0249 Boehringer Ingelheim Investigational Site St Louis Missouri — —
1160.26.0027 Boehringer Ingelheim Investigational Site Kalispell Montana — —
1160.26.0128 Boehringer Ingelheim Investigational Site Alliance Nebraska — —
1160.26.0110 Boehringer Ingelheim Investigational Site Omaha Nebraska — —
1160.26.0355 Boehringer Ingelheim Investigational Site Papillion Nebraska — —
1160.26.0346 Boehringer Ingelheim Investigational Site Henderson Nevada — —
1160.26.0066 Boehringer Ingelheim Investigational Site Las Vegas Nevada — —
1160.26.0174 Boehringer Ingelheim Investigational Site Las Vegas Nevada — —
1160.26.0430 Boehringer Ingelheim Investigational Site Las Vegas Nevada — —
1160.26.0190 Boehringer Ingelheim Investigational Site Lebanon New Hampshire — —
1160.26.0142 Boehringer Ingelheim Investigational Site Browns Mills New Jersey — —
1160.26.0125 Boehringer Ingelheim Investigational Site Cherry Hill New Jersey — —
1160.26.0432 Boehringer Ingelheim Investigational Site Elmer New Jersey — —
1160.26.0448 Boehringer Ingelheim Investigational Site Englewood New Jersey — —
1160.26.0248 Boehringer Ingelheim Investigational Site Flemington New Jersey — —
1160.26.0244 Boehringer Ingelheim Investigational Site Haddon Heights New Jersey — —
1160.26.0243 Boehringer Ingelheim Investigational Site New Brunswick New Jersey — —
1160.26.0478 Boehringer Ingelheim Investigational Site Oakland New Jersey — —
1160.26.0392 Boehringer Ingelheim Investigational Site Ocean City New Jersey — —
1160.26.0472 Boehringer Ingelheim Investigational Site Paterson New Jersey — —
1160.26.0221 Boehringer Ingelheim Investigational Site Voorhees Township New Jersey — —
1160.26.0254 Boehringer Ingelheim Investigational Site Westwood New Jersey — —
1160.26.0127 Boehringer Ingelheim Investigational Site Albuquerque New Mexico — —
1160.26.0423 Boehringer Ingelheim Investigational Site Albuquerque New Mexico — —
1160.26.0476 Boehringer Ingelheim Investigational Site Albany New York — —
1160.26.0063 Boehringer Ingelheim Investigational Site Buffalo New York — —
1160.26.0044 Boehringer Ingelheim Investigational Site Cortlandt Manor New York — —
1160.26.0373 Boehringer Ingelheim Investigational Site Flushing New York — —
1160.26.0045 Boehringer Ingelheim Investigational Site Garden City New York — —
1160.26.0251 Boehringer Ingelheim Investigational Site Kingston New York — —
1160.26.0229 Boehringer Ingelheim Investigational Site Mineola New York — —
1160.26.0451 Boehringer Ingelheim Investigational Site Mineola New York — —
1160.26.0090 Boehringer Ingelheim Investigational Site New Hyde Park New York — —
1160.26.0183 Boehringer Ingelheim Investigational Site New Rochelle New York — —
1160.26.0316 Boehringer Ingelheim Investigational Site New York New York — —
1160.26.0146 Boehringer Ingelheim Investigational Site North Massapequa New York — —
1160.26.0210 Boehringer Ingelheim Investigational Site Northport New York — —
1160.26.0075 Boehringer Ingelheim Investigational Site Poughkeepsie New York — —
1160.26.0197 Boehringer Ingelheim Investigational Site Rochester New York — —
1160.26.0320 Boehringer Ingelheim Investigational Site Rochester New York — —
1160.26.0064 Boehringer Ingelheim Investigational Site Scarsdale New York — —
1160.26.0113 Boehringer Ingelheim Investigational Site The Bronx New York — —
1160.26.0281 Boehringer Ingelheim Investigational Site The Bronx New York — —
1160.26.0414 Boehringer Ingelheim Investigational Site Troy New York — —
1160.26.0356 Boehringer Ingelheim Investigational Site Watertown New York — —
1160.26.0039 Boehringer Ingelheim Investigational Site Williamsville New York — —
1160.26.0353 Boehringer Ingelheim Investigational Site Asheville North Carolina — —
1160.26.0080 Boehringer Ingelheim Investigational Site Charlotte North Carolina — —
1160.26.0412 Boehringer Ingelheim Investigational Site Charlotte North Carolina — —
1160.26.0350 Boehringer Ingelheim Investigational Site Gastonia North Carolina — —
1160.26.0322 Boehringer Ingelheim Investigational Site Greensboro North Carolina — —
1160.26.0173 Boehringer Ingelheim Investigational Site High Point North Carolina — —
1160.26.0108 Boehringer Ingelheim Investigational Site Lexington North Carolina — —
1160.26.0006 Boehringer Ingelheim Investigational Site Pinehurst North Carolina — —
1160.26.0002 Boehringer Ingelheim Investigational Site Statesville North Carolina — —
1160.26.0069 Boehringer Ingelheim Investigational Site Statesville North Carolina — —
1160.26.0372 Boehringer Ingelheim Investigational Site Wilmington North Carolina — —
1160.26.0094 Boehringer Ingelheim Investigational Site Winston-Salem North Carolina — —
1160.26.0425 Boehringer Ingelheim Investigational Site Winston-Salem North Carolina — —
1160.26.0102 Boehringer Ingelheim Investigational Site Grand Forks North Dakota — —
1160.26.0222 Boehringer Ingelheim Investigational Site Jamestown North Dakota — —
1160.26.0203 Boehringer Ingelheim Investigational Site Akron Ohio — —
1160.26.0434 Boehringer Ingelheim Investigational Site Canal Fulton Ohio — —
1160.26.0083 Boehringer Ingelheim Investigational Site Cincinnati Ohio — —
1160.26.0402 Boehringer Ingelheim Investigational Site Cincinnati Ohio — —
1160.26.0426 Boehringer Ingelheim Investigational Site Cincinnati Ohio — —
1160.26.0479 Boehringer Ingelheim Investigational Site Cincinnati Ohio — —
1160.26.0263 Boehringer Ingelheim Investigational Site Cleveland Ohio — —
1160.26.0480 Boehringer Ingelheim Investigational Site Cleveland Ohio — —
1160.26.0267 Boehringer Ingelheim Investigational Site Columbus Ohio — —
1160.26.0035 Boehringer Ingelheim Investigational Site Dayton Ohio — —
1160.26.0150 Boehringer Ingelheim Investigational Site Fairview Park Ohio — —
1160.26.0201 Boehringer Ingelheim Investigational Site Kettering Ohio — —
1160.26.0223 Boehringer Ingelheim Investigational Site Lorain Ohio — —
1160.26.0214 Boehringer Ingelheim Investigational Site Lyndhurst Ohio — —
1160.26.0275 Boehringer Ingelheim Investigational Site Sandusky Ohio — —
1160.26.0103 Boehringer Ingelheim Investigational Site Westlake Ohio — —
1160.26.0155 Boehringer Ingelheim Investigational Site Bartlesville Oklahoma — —
1160.26.0435 Boehringer Ingelheim Investigational Site Tulsa Oklahoma — —
1160.26.0139 Boehringer Ingelheim Investigational Site Corvallis Oregon — —
1160.26.0325 Boehringer Ingelheim Investigational Site Eugene Oregon — —
1160.26.0078 Boehringer Ingelheim Investigational Site Hillsboro Oregon — —
1160.26.0245 Boehringer Ingelheim Investigational Site Portland Oregon — —
1160.26.0133 Boehringer Ingelheim Investigational Site Springfield Oregon — —
1160.26.0301 Boehringer Ingelheim Investigational Site Allentown Pennsylvania — —
1160.26.0454 Boehringer Ingelheim Investigational Site Altoona Pennsylvania — —
1160.26.0295 Boehringer Ingelheim Investigational Site Camp Hill Pennsylvania — —
1160.26.0294 Boehringer Ingelheim Investigational Site Hershey Pennsylvania — —
1160.26.0369 Boehringer Ingelheim Investigational Site Jenkintown Pennsylvania — —
1160.26.0303 Boehringer Ingelheim Investigational Site Jersey Shore Pennsylvania — —
1160.26.0431 Boehringer Ingelheim Investigational Site Lancaster Pennsylvania — —
1160.26.0168 Boehringer Ingelheim Investigational Site Langhorne Pennsylvania — —
1160.26.0293 Boehringer Ingelheim Investigational Site Meadowbrook Pennsylvania — —
1160.26.0025 Boehringer Ingelheim Investigational Site Newton Pennsylvania — —
1160.26.0394 Boehringer Ingelheim Investigational Site Norristown Pennsylvania — —
1160.26.0158 Boehringer Ingelheim Investigational Site Philadelphia Pennsylvania — —
1160.26.0181 Boehringer Ingelheim Investigational Site Philadelphia Pennsylvania — —
1160.26.0416 Boehringer Ingelheim Investigational Site Philadelphia Pennsylvania — —
1160.26.0344 Boehringer Ingelheim Investigational Site Pittsburgh Pennsylvania — —
1160.26.0466 Boehringer Ingelheim Investigational Site Pittsburgh Pennsylvania — —
1160.26.0208 Boehringer Ingelheim Investigational Site Sellersville Pennsylvania — —
1160.26.0465 Boehringer Ingelheim Investigational Site Uniontown Pennsylvania — —
1160.26.0400 Boehringer Ingelheim Investigational Site Upland Pennsylvania — —
1160.26.0032 Boehringer Ingelheim Investigational Site Wynnewood Pennsylvania — —
1160.26.0067 Boehringer Ingelheim Investigational Site Wyomissing Pennsylvania — —
1160.26.0212 Boehringer Ingelheim Investigational Site Pawtucket Rhode Island — —
1160.26.0007 Boehringer Ingelheim Investigational Site Beaufort South Carolina — —
1160.26.0383 Boehringer Ingelheim Investigational Site Charleston South Carolina — —
1160.26.0313 Boehringer Ingelheim Investigational Site Greenville South Carolina — —
1160.26.0450 Boehringer Ingelheim Investigational Site Mt. Pleasant South Carolina — —
1160.26.0166 Boehringer Ingelheim Investigational Site Spartanburg South Carolina — —
1160.26.0008 Boehringer Ingelheim Investigational Site Summerville South Carolina — —
1160.26.0468 Boehringer Ingelheim Investigational Site West Columbia South Carolina — —
1160.26.0348 Boehringer Ingelheim Investigational Site Rapid City South Dakota — —
1160.26.0084 Boehringer Ingelheim Investigational Site Chattanooga Tennessee — —
1160.26.0062 Boehringer Ingelheim Investigational Site Germantown Tennessee — —
1160.26.0370 Boehringer Ingelheim Investigational Site Johnson City Tennessee — —
1160.26.0323 Boehringer Ingelheim Investigational Site Nashville Tennessee — —
1160.26.0395 Boehringer Ingelheim Investigational Site Nashville Tennessee — —
1160.26.0474 Boehringer Ingelheim Investigational Site Oak Ridge Tennessee — —
1160.26.0129 Boehringer Ingelheim Investigational Site Austin Texas — —
1160.26.0410 Boehringer Ingelheim Investigational Site Austin Texas — —
1160.26.0156 Boehringer Ingelheim Investigational Site Dallas Texas — —
1160.26.0315 Boehringer Ingelheim Investigational Site Fort Worth Texas — —
1160.26.0444 Boehringer Ingelheim Investigational Site Fort Worth Texas — —
1160.26.0447 Boehringer Ingelheim Investigational Site Houston Texas — —
1160.26.0483 Boehringer Ingelheim Investigational Site Killeen Texas — —
1160.26.0335 Boehringer Ingelheim Investigational Site Lubbock Texas — —
1160.26.0230 Boehringer Ingelheim Investigational Site McKinney Texas — —
1160.26.0467 Boehringer Ingelheim Investigational Site Plano Texas — —
1160.26.0013 Boehringer Ingelheim Investigational Site San Antonio Texas — —
1160.26.0269 Boehringer Ingelheim Investigational Site San Antonio Texas — —
1160.26.0307 Boehringer Ingelheim Investigational Site San Antonio Texas — —
1160.26.0285 Boehringer Ingelheim Investigational Site San Marcos Texas — —
1160.26.0215 Boehringer Ingelheim Investigational Site Tyler Texas — —
1160.26.0367 Boehringer Ingelheim Investigational Site Tyler Texas — —
1160.26.0195 Boehringer Ingelheim Investigational Site Arlington Virginia — —
1160.26.0453 Boehringer Ingelheim Investigational Site Charlottesville Virginia — —
1160.26.0053 Boehringer Ingelheim Investigational Site Chesapeake Virginia — —
1160.26.0098 Boehringer Ingelheim Investigational Site Danville Virginia — —
1160.26.0386 Boehringer Ingelheim Investigational Site Falls Church Virginia — —
1160.26.0428 Boehringer Ingelheim Investigational Site Fredericksburg Virginia — —
1160.26.0311 Boehringer Ingelheim Investigational Site Harrisonburg Virginia — —
1160.26.0292 Boehringer Ingelheim Investigational Site Newport News Virginia — —
1160.26.0224 Boehringer Ingelheim Investigational Site Norfolk Virginia — —
1160.26.0220 Boehringer Ingelheim Investigational Site Salem Virginia — —
1160.26.0317 Boehringer Ingelheim Investigational Site Winchester Virginia — —
1160.26.0287 Boehringer Ingelheim Investigational Site Bellevue Washington — —
1160.26.0050 Boehringer Ingelheim Investigational Site Bellingham Washington — —
1160.26.0040 Boehringer Ingelheim Investigational Site Burien Washington — —
1160.26.0298 Boehringer Ingelheim Investigational Site Olympia Washington — —
1160.26.0250 Boehringer Ingelheim Investigational Site Spokane Washington — —
1160.26.0256 Boehringer Ingelheim Investigational Site Tacoma Washington — —
1160.26.0024 Boehringer Ingelheim Investigational Site Wenatchee Washington — —
1160.26.0193 Boehringer Ingelheim Investigational Site Charleston West Virginia — —
1160.26.0169 Boehringer Ingelheim Investigational Site Clarksburg West Virginia — —
1160.26.0365 Boehringer Ingelheim Investigational Site Huntington West Virginia — —
1160.26.0072 Boehringer Ingelheim Investigational Site Elkhorn Wisconsin — —
1160.26.0234 Boehringer Ingelheim Investigational Site Green Bay Wisconsin — —
1160.26.0099 Boehringer Ingelheim Investigational Site Madison Wisconsin — —
1160.26.0242 Boehringer Ingelheim Investigational Site Madison Wisconsin — —
1160.26.0359 Boehringer Ingelheim Investigational Site Marshfield Wisconsin — —
1160.26.0461 Boehringer Ingelheim Investigational Site Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 610 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00262600, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00262600 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →